Here are some of the biggest patent myths founders believe — and a practical, startup-friendly IP strategy tied to business ...

First, Fully Synthetic Recombinant Version of PRPMELBOURNE, , Jan. 20, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused ...

China doesn’t just require speed in filing. It demands strategy. The costs of getting it wrong aren’t always immediate, but ...

Member Insights: The Hidden Costs Of Getting Your Chinese IP Strategy Wrong ...

The expanded JS-SEZ could create a more integrated and attractive proposition for global investors, says SBF and PwC Read ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases ...

Internal emails, texts, slide decks, and deposition testimony show how Microsoft went from being sidelined at OpenAI’s ...

The latest incarnation of the notorious BreachForums hacking forum has suffered a data breach, with its user database table ...

Researchers found the popular model context protocol (MCP) servers, which are integral components of AI services, carry ...

In today's environment, marked by heightened enforcement and stricter rules, the quality of year-end TP execution can ...

Private hospital IP rider premiums have grown at an average of 17% annually for the past three years, double that of IP ...

FAR (Federal Acquisition Regulation) and DFARS (Defense Federal Acquisition Regulation Supplement) are the primary ...